[Neuropharmacologic effect of 2 newly synthesized compounds of the piperazine group. Report II. Effect on the behavior of experimental animals].
Ianeva-Balabanska
I
I
Staneva-Stoĭcheva
D
D
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006146:Guanidines / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009125:Muscle Relaxants, Central; D009949:Orientation / Q000187:drug effects* / Q000502:physiology; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014149:Tranquilizing Agents
D006146:Guanidines; D009125:Muscle Relaxants, Central; D010879:Piperazines; D014149:Tranquilizing Agents; C050210:1-benzyl-4-(guanidinoiminomethyl)piperazine; C058604:GP 4
Nevrofarmakologichna aktivnost na dve novosintezirani suedineniia ot grupata na piperazina. II. Suobshchenie. Vliianie vurkhu povedenieto na eksperimentalni zhivotni.